Literature DB >> 4129869

Inhibition of drug metabolism in man.

E S Vesell, G T Passananti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4129869

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  12 in total

1.  Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.

Authors:  J M Bell; C J Russell; J K Nelson; J G Kelly; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

Review 2.  Research review. Interactions between environmental chemicals and drug biotransformation in man.

Authors:  A P Alvares
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

Review 3.  Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.

Authors:  Gail D Anderson; Lingtak-Neander Chan
Journal:  Clin Pharmacokinet       Date:  2016-11       Impact factor: 6.447

Review 4.  Role of tobacco smoking in pharmacokinetics.

Authors:  W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1978-02

Review 5.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 6.  Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.

Authors:  S M MacLeod; E M Sellers
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Effect of ticlopidine treatment on liver metabolizing enzymes in man.

Authors:  J J Thebault; C Blatrix; J Blanchard; E Panak
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

8.  Enhanced drug metabolism in cigarette smokers.

Authors:  P Hart; G C Farrell; W G Cooksley; L W Powell
Journal:  Br Med J       Date:  1976-07-17

9.  The metabolism of methaqualone in patients with biliary cirrhosis or secondary carcinoma of the liver.

Authors:  D Burnett; C N Reynolds; K Wilson
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

10.  Elimination of pindolol in liver disease.

Authors:  E E Ohnhaus; U Münch; J Meier
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.